Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6796 AL 6810

Neuroprotective Role of Phytochemicals

Velmurugan BK, Rathinasamy B, Lohanathan BP, Thiyagarajan V, Weng CF.

Molecules. 2018 Sep 27;23(10):2485. doi: 10.3390/molecules23102485.

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases

Singh YP, Pandey A, Vishwakarma S, Modi G.

Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.

Golden oldies and silver brains: Deficits, preservation, learning, and rehabilitation effects of music in ageing-related neurological disorders

Särkämö T, Sihvonen AJ.

Cortex. 2018 Dec;109:104-123. doi: 10.1016/j.cortex.2018.08.034. Epub 2018 Sep 19.

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases

Teijido O, Cacabelos R.

Int J Mol Sci. 2018 Oct 16;19(10):3199. doi: 10.3390/ijms19103199.

Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease

Zhao L, Cheng X, Zhong C.

ACS Chem Neurosci. 2019 Feb 20;10(2):922-930. doi: 10.1021/acschemneuro.8b00450. Epub 2018 Dec 12.

Vitamin D basis of Alzheimer's disease: from genetics to biomarkers

Dursun E, Gezen-Ak D.

Hormones (Athens). 2019 Mar;18(1):7-15. doi: 10.1007/s42000-018-0086-5. Epub 2018 Nov 27.

Acute inability to mobilise resulting from probable donepezil-induced myoclonus

Whateley JM, Huffman AJ, Henderson EJ.

Age Ageing. 2018 Nov 1;47(6):907-908. doi: 10.1093/ageing/afy093.

Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease

Cretin B.

Expert Opin Pharmacother. 2018 Aug;19(11):1201-1209. doi: 10.1080/14656566.2018.1496237. Epub 2018 Jul 14.

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity

Parsons CG.

Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27.

Deep brain stimulation: potential for neuroprotection

McKinnon C, Gros P, Lee DJ, Hamani C, Lozano AM, Kalia LV, Kalia SK.

Ann Clin Transl Neurol. 2018 Nov 8;6(1):174-185. doi: 10.1002/acn3.682. eCollection 2019 Jan.

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease

Rahman SO, Singh RK, Hussain S, Akhtar M, Najmi AK.

Eur J Pharmacol. 2019 Jan 5;842:208-220. doi: 10.1016/j.ejphar.2018.10.040. Epub 2018 Oct 30.

Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Bali P, Lahiri DK, Banik A, Nehru B, Anand A.

Curr Alzheimer Res. 2017;14(2):208-220. doi: 10.2174/1567205013666160314145347.

Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease

Mondragón-Rodríguez S, Perry G, Pena-Ortega F, Williams S.

Curr Alzheimer Res. 2017;14(1):40-46. doi: 10.2174/1567205013666160819131336.

Deep Brain Stimulation for Alzheimer's Disease

Xu DS, Ponce FA.

Curr Alzheimer Res. 2017;14(4):356-361. doi: 10.2174/1567205013666161014124945.

Nanomedicine in brain repair: Alzheimer's, Parkinson's and the proteome

Broderick PA, Jacoby JH.

J Neural Transm (Vienna). 2017 Jan;124(1):1. doi: 10.1007/s00702-016-1660-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias